Shuttle Pharmaceuticals Holdings Inc (SHPH)
1.32
-0.03
(-2.22%)
USD |
NASDAQ |
Sep 27, 16:00
1.29
-0.03
(-2.27%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings SG&A Expense (Annual): 2.375M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.375M |
| December 31, 2022 | 1.296M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.7212M |
| December 31, 2020 | 0.3478M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
0.3478M
Minimum
2020
2.375M
Maximum
2023
1.185M
Average
1.009M
Median
SG&A Expense (Annual) Benchmarks
| Oragenics Inc | 5.452M |
| Soligenix Inc | 4.483M |
| Tonix Pharmaceuticals Holding Corp | 34.75M |
| Lixte Biotechnology Holdings Inc | 4.192M |
| NovaBay Pharmaceuticals Inc | 12.83M |